Work

CMR-Verified Regression of Cardiac AL Amyloid After Chemotherapy

Year: 2017

Type: article

Study design: Observational Study

Source: JACC. Cardiovascular imaging

DOI: 10.1016/j.jcmg.2017.02.012

Authors: Ana Martinez-Naharro, Amna Abdel-Gadir, Thomas A. Treibel, Giulia Zumbo, Daniel S. Knight, Stefania Rosmini, Thirusha Lane, Shameem Mahmood, Sajitha Sachchithanantham, Carol J. Whelan, Helen J. Lachmann, Ashutosh D. Wechalekar, Peter Kellman, Julian D. Gillmore, James C. Moon, Philip N. Hawkins, Marianna Fontana

Institutions: The Royal Free Hospital, National Institute for Health and Care Research, Royal Brompton Hospital, NIHR Royal Brompton Cardiovascular Biomedical Research Unit, University College London

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institute for Health and Care Research, British Heart Foundation, Imperial College London, Fédération Française de Cardiologie

Awards: G2694883840, The Role of Diffuse Myocardial Fibrosis in Aortic Stenosis: Translation of Non-Invasive Quantification into Clinical Practice, Anti-atherogenic effects of anti-platelet drugs in patients with silent atherosclerosis, Predicting cardiac events in congenital heart disease: the role of focal and interstitial fibrosis

OpenAlex ID: W2606253069

FWCI: 3.397

Cites: 4

Cited by: 134

Related to: 10